HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lettesjö, H. Articles by Mageed, R. A. Search for Related Content PubMed PubMed Citation Articles by Lettesjö, H. Articles by Mageed, R. A.

CD4⁺ T Lymphocytes with Constitutive CD40 Ligand in Preautoimmune (NZB x NZW)F₁ Lupus-Prone Mice: Phenotype and Possible Role in Autoreactivity¹

The Kennedy Institute of Rheumatology, Hammersmith, London, United Kingdom

Lupus disease is marked by B lymphocyte hyperactivity and the production of Abs to dsDNA. The production of these anti-dsDNA Abs is T lymphocyte dependent. However, it is not clear how CD4⁺ T lymphocytes provide help for B lymphocytes to produce IgG anti-dsDNA Abs. One possible mechanism is suggested by studies showing that human patients with systemic lupus erythematosus and lupus mice have increased numbers of CD40 ligand (CD40L)⁺ T and B lymphocytes. The results described in this study reveal that young, clinically healthy lupus-prone New Zealand Black x New Zealand White F₁ (BWF₁) mice have naive CD4⁺ T cells with preformed CD40L. These cells contribute to a brisk response to immunization and to the production of anti-dsDNA Abs. In vitro experiments revealed that CD4⁺ T cells with preformed CD40L could, upon stimulation, provide antiapoptotic signals for B cells but could not induce proliferation or reduce activation threshold. These results suggest that the direct target cells for the effect of T cells with preformed CD40L in lupus may not be B lymphocytes.

This article has been cited by other articles:

				A. Martin-Fontecha, D. Baumjohann, G. Guarda, A. Reboldi, M. Hons, A. Lanzavecchia, and F. Sallusto CD40L+ CD4+ memory T cells migrate in a CD62P-dependent fashion into reactive lymph nodes and license dendritic cells for T cell priming J. Exp. Med., October 27, 2008; 205(11): 2561 - 2574. [Abstract] [Full Text] [PDF]

				Y. Koguchi, T. J. Thauland, M. K. Slifka, and D. C. Parker Preformed CD40 ligand exists in secretory lysosomes in effector and memory CD4+ T cells and is quickly expressed on the cell surface in an antigen-specific manner Blood, October 1, 2007; 110(7): 2520 - 2527. [Abstract] [Full Text] [PDF]

				M. Dranitzki-Elhalel, J. H. Huang, M. Sasson, J. Rachmilewitz, M. Parnas, and M. L. Tykocinski CD40{middle dot}FasL inhibits human T cells: evidence for an auto-inhibitory loop-back mechanism Int. Immunol., April 1, 2007; 19(4): 355 - 363. [Abstract] [Full Text] [PDF]

				R. Lesley, L. M. Kelly, Y. Xu, and J. G. Cyster Naive CD4 T cells constitutively express CD40L and augment autoreactive B cell survival PNAS, July 11, 2006; 103(28): 10717 - 10722. [Abstract] [Full Text] [PDF]

				G. Terrazzano, M. Sica, C. Becchimanzi, S. Costantini, B. Rotoli, S. Zappacosta, F. Alfinito, and G. Ruggiero T cells from paroxysmal nocturnal haemoglobinuria (PNH) patients show an altered CD40-dependent pathway J. Leukoc. Biol., July 1, 2005; 78(1): 27 - 36. [Abstract] [Full Text] [PDF]

				N. Fujita, H. Kagamu, H. Yoshizawa, K. Itoh, H. Kuriyama, N. Matsumoto, T. Ishiguro, J. Tanaka, E. Suzuki, H. Hamada, et al. CD40 Ligand Promotes Priming of Fully Potent Antitumor CD4+ T Cells in Draining Lymph Nodes in the Presence of Apoptotic Tumor Cells J. Immunol., November 15, 2001; 167(10): 5678 - 5688. [Abstract] [Full Text] [PDF]